Skip to main content
IMS Events Main banner
Back

    Meral Beksac, MD (she/her/hers)

    Professor of Hematology
    Istinye University
    Ankara, Turkey

    Meral Beksaç MD, is a Professor in Ankara Liv Hospital Hematology and Stem Cell Transplantation Unit, affiliated with Istinye University. She has been actively involved in investigator initiated or pharma sponsored phase II-III clinical trials since 1992, initially within the auspices of EORTC-LCG and most recently in collaboration with European Myeloma Network.

    She received her medical and postgraduate training mainly in Ankara, Turkey, with experience as a visiting scientist or clinician in various Institutions including Karolinska Hospital, Sweden, Heidelberg University, Royal Marsden Hospital, University College Hospital and various institutions in USA.

    Dr Beksaç is an active member of Turkish Society of Hematology as well as international hematological societies, including EHA, ASH, EBMT, ASBMT, International Myeloma Society(IMS) and IMF. She is currently the president of the” Turkish Bone Marrow Transplantation Foundation” is currently chairing the “Myeloma” Subcommittee of the Turkish Society of Hematology”. She has pioneered the collaboration between Clinical teams, publishing the first Turkish prospective randomized trials in AML and Myeloma in Turkey. She has recently been elected as a board member of European Myeloma Network, the vice-chair of the “Balkan Myeloma Study Group” and also the Plasma Cell Disorders Subcommittee of EBMT-CMWP.

    Dr Beksaç is also a member of the editorial board of scientific journals and has published many book chapters and more than 250 original papers in peer-reviewed journals with more than 24000 citations (H index:61). Professor Beksaç is editor and author of the book Bone Marrow and Stem Cell Transplantation, published by Springer in 2007 (first ed) and 2014(second ed). She has been an elected member of the Turkish Academy of Sciences following its foundation in 1994. Meral Beksac has served in the EHA Scientific Program Committee, for a term (2013-2016).

    Disclosure information not submitted.

    Presentation(s):